These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20380933)

  • 61. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease?
    Kwon S; Kim YK; Park HJ; Jeong WK; Lee WJ; Choi D
    Magn Reson Imaging; 2014 Dec; 32(10):1214-22. PubMed ID: 25192607
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Korean J Radiol; 2008; 9(6):510-9. PubMed ID: 19039267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography.
    Yukisawa S; Okugawa H; Masuya Y; Okabe S; Fukuda H; Yoshikawa M; Ebara M; Saisho H
    Eur J Radiol; 2007 Feb; 61(2):279-89. PubMed ID: 17070663
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
    Lim S; Kim YK; Park HJ; Lee WJ; Choi D; Park MJ
    J Magn Reson Imaging; 2014 May; 39(5):1238-45. PubMed ID: 24136725
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatic lesion detection at MR imaging: a comparative study with four sequences.
    Blakeborough A; Ward J; Wilson D; Griffiths M; Kajiya Y; Guthrie JA; Robinson PJ
    Radiology; 1997 Jun; 203(3):759-65. PubMed ID: 9169701
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography.
    Kwak HS; Lee JM; Kim CS
    Eur Radiol; 2004 Mar; 14(3):447-57. PubMed ID: 14531005
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods.
    Holzapfel K; Eiber MJ; Fingerle AA; Bruegel M; Rummeny EJ; Gaa J
    Abdom Imaging; 2012 Feb; 37(1):74-82. PubMed ID: 21597893
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
    Park MJ; Kim YK; Lim S; Rhim H; Lee WJ
    Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T.
    Song KD; Kim YK; Lee WJ; Lee MW; Park MJ; Hwang J; Lee MH
    Acta Radiol; 2012 Jun; 53(5):485-93. PubMed ID: 22535883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
    Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
    J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria.
    Rhee H; Kim MJ; Park YN; Choi JS; Kim KS
    J Magn Reson Imaging; 2012 Feb; 35(2):393-8. PubMed ID: 21990116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
    Lee JM; Kim IH; Kwak HS; Youk JH; Han YM; Kim CS
    Korean J Radiol; 2003; 4(1):1-8. PubMed ID: 12679628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
    Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique--evaluation of SPIO-enhanced T2-weighted MR images.
    Hirokawa Y; Isoda H; Maetani YS; Arizono S; Shimada K; Okada T; Shibata T; Togashi K
    Radiology; 2009 May; 251(2):388-97. PubMed ID: 19401572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.
    Limanond P; Raman SS; Sayre J; Lu DS
    J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.
    Park Y; Kim SH; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ; Kim H; Koo JH; Lim HK
    Korean J Radiol; 2010; 11(4):433-40. PubMed ID: 20592927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.